Back to Search

PATRICK DESIMONE, PHARMD

PHARMD

Pharmacist

NPI: 1295052108Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

RP439905(PA)

Research & Publications (11)

Evaluation of an uncalibrated arterial pulse contour cardiac output monitoring system in cirrhotic patients undergoing liver surgery.
PMID 19059920·Br J Anaesth·2009
8-other
A four-arm, randomized, multicenter phase II trial of oxaliplatin combined with varying schedules of 5-fluorouracil as first-line therapy in previously untreated advanced colorectal cancer.
PMID 18501073·Clin Colorectal Cancer·2008
3-trial
Cancer family history reporting: impact of method and psychosocial factors.
PMID 17318453·J Genet Couns·2007
2-rct
Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.
PMID 17311704·Clin Colorectal Cancer·2007
5-case
Nurses' knowledge and application of evidence-based guidelines for preventing ventilator-associated pneumonia.
PMID 17115016·Minerva Anestesiol·2007
8-other
Dose-escalation study of ICA-17043 in patients with sickle cell disease.
PMID 17064199·Pharmacotherapy·2006
3-trial
Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.
PMID 15528979·Invest New Drugs·2005
3-trial
Low-dose fractionated radiation as a chemopotentiator of neoadjuvant paclitaxel and carboplatin for locally advanced squamous cell carcinoma of the head and neck: results of a new treatment paradigm.
PMID 15050317·Int J Radiat Oncol Biol Phys·2004
3-trial
Durable local responses with subtherapeutic doses of concurrent radiation and gemcitabine in a patient with refractory Hodgkin's disease.
PMID 16258425·Clin Adv Hematol Oncol·2003
5-case
Clinical protocol. An open-label, phase I, dose-escalation study of tumor necrosis factor-alpha (TNFerade Biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors.
PMID 11399232·Hum Gene Ther·2001
8-other
Treatment of anaplastic thyroid carcinoma with paclitaxel: phase 2 trial using ninety-six-hour infusion. Collaborative Anaplastic Thyroid Cancer Health Intervention Trials (CATCHIT) Group.
PMID 10958311·Thyroid·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
3700 WALNUT ST
MCKEESPORT, PA 15132

Location

Practice Location

3700 WALNUT ST, MCKEESPORT, PA
(412) 751-0132

Quick Facts

NPI
1295052108
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
11

Are you this provider?

Claim Your Profile